Nathalie Lapointe
About
In The Last Decade
Nathalie Lapointe
19 papers receiving 596 citations
Peers
Comparison fields: 5 of 68
- Cardiology and Cardiovascular Medicine 302
- Endocrinology, Diabetes and Metabolism 223
- Molecular Biology 212
- Surgery 119
- Physiology 101
Countries citing papers authored by Nathalie Lapointe
This map shows the geographic impact of Nathalie Lapointe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathalie Lapointe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathalie Lapointe more than expected).
Fields of papers citing papers by Nathalie Lapointe
This network shows the impact of papers produced by Nathalie Lapointe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathalie Lapointe. The network helps show where Nathalie Lapointe may publish in the future.
Co-authorship network of co-authors of Nathalie Lapointe
This figure shows the co-authorship network connecting the top 25 collaborators of Nathalie Lapointe. A scholar is included among the top collaborators of Nathalie Lapointe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathalie Lapointe. Nathalie Lapointe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 31 | |
| 2 | 49 | |
| 3 | 15 | |
| 4 | 147 | |
| 5 | 2 | |
| 6 | 27 | |
| 7 | 20 | |
| 8 | 5 | |
| 9 | 11 | |
| 10 | 48 | |
| 11 | The OPTIMAAL study, not so optimal: the lessons of LIFE, RENAAL and IDNT. | 1 |
| 12 | 39 | |
| 13 | 6 | |
| 14 | 8 | |
| 15 | Angiotensin receptor blockers: powerful evidence with cardiovascular outcomes? | 18 |
| 16 | 114 | |
| 17 | Cardioprotective effects of vasopeptidase inhibitors. | 19 |
| 18 | 9 | |
| 19 | 37 | |
| 20 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.